Literature DB >> 16979622

Increased iron deposition in rat liver fibrosis induced by a high-dose injection of dimethylnitrosamine.

Limei Guo1, Hideaki Enzan, Yoshihiro Hayashi, Eriko Miyazaki, Yulan Jin, Makoto Toi, Naoto Kuroda, Makoto Hiroi.   

Abstract

Using a developed rat model of hepatic necrosis and subsequent fibrosis induced by a high-dose intraperitoneal injection of dimethylnitrosamine (DMN), we studied iron deposition and expression of transforming growth factor-beta(1) (TGF-beta(1)) during the development of persistent liver fibrosis. Rats were sacrificed at several timepoints from 6 h to 10 months post-injection and the livers were examined for iron content and distribution, and for expression of alpha-smooth muscle actin, ED-1, TGF-beta(1), and collagen (alpha(2))I. Morphologic evidence of acute submassive hemorrhagic necrosis peaked at 36 h; on day 3 the residual parenchyma contained activated hepatic stellate cells (HSCs) and necrotic areas contained numerous macrophages; and on day 5, necrotic tissues and erythrocytes had been phagocytosed and macrophages contained abundant iron deposits. From days 7 to 10, iron-laden macrophages and activated HSCs (myofibroblasts) populated the fibrous septa in parallel. From week 2 to month 10, closely arranged macrophages and myofibroblasts were found in central-to-central bridging fibrotic tissue. TGF-beta(1) was strongly detected in both macrophages and HSCs during development of liver fibrosis. Our data suggest that increased iron deposition may be involved in the initiation and perpetuation of rat liver fibrosis. Iron-laden macrophages may influence HSCs through the action of TGF-beta(1) in DMN-induced liver fibrosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16979622     DOI: 10.1016/j.yexmp.2006.07.006

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  4 in total

Review 1.  Epidemilogical trends strongly suggest exposures as etiologic agents in the pathogenesis of sporadic Alzheimer's disease, diabetes mellitus, and non-alcoholic steatohepatitis.

Authors:  Suzanne M de la Monte; Alexander Neusner; Jennifer Chu; Margot Lawton
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 2.  Hydrogen Sulfide as a Potential Therapeutic Target in Fibrosis.

Authors:  Shufang Zhang; Chuli Pan; Feifei Zhou; Zhi Yuan; Huiying Wang; Wei Cui; Gensheng Zhang
Journal:  Oxid Med Cell Longev       Date:  2015-05-11       Impact factor: 6.543

3.  The interplay of the Notch signaling in hepatic stellate cells and macrophages determines the fate of liver fibrogenesis.

Authors:  Ruchi Bansal; Joop van Baarlen; Gert Storm; Jai Prakash
Journal:  Sci Rep       Date:  2015-12-14       Impact factor: 4.379

4.  Determination of Hepatic Iron Deposition in Drug-Induced Liver Fibrosis in Rats by Confocal Micro-XRF Spectrometry.

Authors:  Qianqian Xu; Wenjing Xia; Lazhen Zhou; Zhengwei Zou; Qiuxia Li; Lijun Deng; Sha Wu; Tao Wang; Jingduo Cui; Zhiguo Liu; Tianxi Sun; Junsong Ye; Fangzuo Li
Journal:  ACS Omega       Date:  2022-01-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.